• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

Lexeo Therapeutics price target rises to $26.12 across 8 analysts

FinanceInternationalTradingViewAI summary
Image: TradingView

According to estimates from 8 analysts, the average price target for Lexeo Therapeutics shares rose from $25.11 to $26.12, with forecasts ranging from $9 to $42 per share. Using the November 20, 2026 closing price as a reference, the new target implies a potential upside of about 783%. The consensus rating from the 8 analysts remains "buy": 8 buy, 0 hold and 0 sell.

In 30 seconds

  • The average price target from 8 analysts rises from $25.11 to $26.12 per share
  • Forecasts range from $9 to $42 per share
  • The new target implies a potential upside of 783% versus the November 20, 2026 close
Read the full story at TradingView

IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading